New & Noteworthy

November 2023

Calcium Gluconate Injection

Amneal Pharmaceuticals

Amneal Pharmaceuticals has received Abbreviated New Drug Application approval from the FDA for calcium gluconate in sodium chloride injection, 1000 mg/50 mL and 2000 mg/100 mL. The product approval received the FDA’s Competitive Generic Therapy designation with 180-day exclusivity.

Request More Information

Current Issue